TyG Index independent marker for detecting Subclinical CAD: Study
Atherosclerotic cardiovascular (CV) events commonly occur in individuals with a low CV risk burden. The researchers evaluated the ability of the triglyceride glucose (TyG) index to predict subclinical coronary artery disease (CAD) in asymptomatic subjects without traditional CV risk factors (CVRFs).
They found that triglyceride glucose index (TyG) was an independent marker for predicting subclinical coronary artery disease (CAD) in individuals with no traditional cardiovascular risk factors (CVRFs) The study has been published in Lipids in Health and Disease.
In this retrospective, cross-sectional, observational study, researchers selected asymptomatic patients with no traditional CVRFs who had undergone self-referred coronary computed tomography angiography. They evaluated the association of TyG index with CAD in 1250 (52.8 ± 6.5 years, 46.9% male) asymptomatic individuals without traditional CVRFs (defined as systolic/diastolic blood pressure ≥ 140/90 mmHg; fasting glucose ≥126 mg/dL; total cholesterol ≥240 mg/dL; low-density lipoprotein cholesterol ≥160 mg/dL; high-density lipoprotein cholesterol < 40 mg/dL; body mass index ≥25.0 kg/m2; current smoking; and previous medical history of hypertension, diabetes, or dyslipidemia). Patients were divided into 3 groups based on TyG index tertiles: group I (mean TyG index, 7.84±0.19), group II (mean TyG index, 8.27±0.11), and group III (mean TyG index, 8.83±0.30). CAD was defined as the presence of any coronary plaque identified on CCTA.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.